Background/aims: Stromal interacting molecule-1 (STIM1) aggregation and redistribution to plasma membrane to interact with Orai1 constitute the core mechanism of store-operated Ca2+ entry (SOCE). Previous study has revealed that calsequestrin-1 (CSQ1) regulates SOCE in HEK293 cells through interacting with STIM1 and inhibiting STIM1/Orai1 interaction. Here, we further investigate how CSQ1/STIM1 interaction affects SOCE.
Methods: Using confocal microscopy, STIM1 aggregation and co-localizations with CSQ1 or Orai1 upon Ca2+ store depletion by thapsigargin were measured and quantified by Imaris software in HeLa cells transfected with different CSQ1 mutants. The interactions of CSQ1/STIM1 and STIM1/Orai1, and internal Ca2+ changes were detected by co-immunoprecipitation and Fura2, respectively.
Results: Wt-CSQ1 overexpression significantly reduced STIM1 clustering in the perimembrane and cytosolic regions, whereas over-expression of a C-terminal amino acid 362-396 deletion mutant (C35) did not. Consistently, a significant depression of SOCE, increased CSQ1 monomerization and CSQ1/STIM1 interaction, and a reduced STIM1/Orai1 association were observed in wt-CSQ1 but not in C35-transfected cells. Additionally, mutant lacking C-terminal AA 388-396 deletion exerted weaker potency in inhibiting STIM1 aggregation and association with Orai1 than wt-CSQ1.
Conclusions: Our results demonstrate that CSQ1 monomers suppress SOCE by interacting with STIM1 and attenuating STIM1 aggregation via its C-terminal amino acid 362-396.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1159/000445574 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A Gain-of-Function Mutation in the Ca Channel ORAI1 Causes Stormorken Syndrome with Tubular Aggregates in Mice.
Cells
November 2024
Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Inserm U1258, CNRS UMR7104, Université de Strasbourg, 67404 Illkirch, France.
Store-operated Ca entry (SOCE) controls Ca homeostasis and mediates multiple Ca-dependent signaling pathways and cellular processes. It relies on the concerted activity of the reticular Ca sensor STIM1 and the plasma membrane Ca channel ORAI1. STIM1 and ORAI1 gain-of-function (GoF) mutations induce SOCE overactivity and excessive Ca influx, leading to tubular aggregate myopathy (TAM) and Stormorken syndrome (STRMK), two overlapping disorders characterized by muscle weakness and a variable occurrence of multi-systemic anomalies affecting spleen, skin, and platelets.
View Article and Find Full Text PDFConstitutive, Muscle-Specific Knockout Results in the Incomplete Assembly of Ca Entry Units and a Reduction in the Age-Dependent Formation of Tubular Aggregates.
Biomedicines
July 2024
Center for Advanced Studies and Technology (CAST), University G. d'Annunzio of Chieti-Pescara, I-66100 Chieti, Italy.
Article Synopsis
- - Store-operated calcium entry (SOCE) is a critical process in cells that helps them maintain calcium levels, especially when internal stores are low, and occurs in specialized regions of skeletal muscle where specific proteins are located.
- - Mutations in certain proteins associated with SOCE are linked to a muscle disorder known as tubular aggregate myopathy, which shows an increase in specific structures as muscles age, particularly in male mice.
- - A study on mice with a muscle-specific knockout of a protein called Orai1 found that these mice had a shorter lifespan, reduced weight, exercise intolerance, and more damaged mitochondria, while also showing changes in muscle structure, including a lack of tubular aggregates with age.
TAM-associated CASQ1 mutants diminish intracellular Ca content and interfere with regulation of SOCE.
J Muscle Res Cell Motil
December 2024
Department of Molecular and Developmental Medicine, University of Siena, Siena, I-53100, Italy.
Article Synopsis
- Tubular aggregate myopathy (TAM) is a rare muscle disorder marked by muscle weakness and pain, linked to specific gene mutations affecting calcium regulation.
- Mutations in STIM1, ORAI1, and the recently identified CASQ1 gene disrupt normal calcium storage and entry in muscle cells, contributing to the disease's symptoms.
- Studies using muscle fibers from mice lacking CASQ1 show that these mutations lead to ineffective calcium storage and loss of calcium entry inhibition, highlighting their role in TAM pathology.
STIM1: A new player in nuclear dynamics? Lessons learnt from tubular aggregate myopathy.
Cell Calcium
November 2024
Department of Drug Science and Technology, University of Turin, Turin, Italy. Electronic address:
Two recent papers have highlighted that STIM1, a key component of Store-operated Ca2+-entry, is able to translocate to the nucleus and participate in nuclear Ca-handling and in DNA repair. These finding opens new avenues on the role that this Ca-sensing protein may have in health and disease.
View Article and Find Full Text PDFORAI1 inhibition as an efficient preclinical therapy for tubular aggregate myopathy and Stormorken syndrome.
JCI Insight
March 2024
Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Inserm U1258, CNRS UMR7104, University of Strasbourg, Illkirch, France.
Article Synopsis
- * Experimental mouse models showed that pairing a TAM mutation (Stim1R304W) with a partial ORAI1 mutation (Orai1R93W) led to positive health outcomes, including improved bone structure, spleen health, muscle function, and increased platelet counts.
- * The study suggests that targeting ORAI1 could offer a potential treatment strategy for TAM/STRMK, and identified myostatin as a potential biom
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!